Supplementation with the green tea compound epigallocatechin 3-gallate (EGCG) could improve gestational diabetes outcomes in both mothers and new-born infants, new data suggests.
Pharmacists in South East Asia need to play a pivotal role in guiding pregnant women to take the correct supplements and combat the widespread ‘misinformation’ that is available online.
Women given a lipid-based supplement during pregnancy have been shown to be 25% more likely to give birth to infants with healthy birth measurements in a country where one in every five babies is born stunted.